Industry: Medical Devices & Consumables
Published Date: 2026-03-26
Pages: 77 Pages
Report ld: 6296164
Request Sample
Customized Report
The global 25G Transconjunctival Sutureless Vitrectomy System market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
In 2025, the North America 25G Transconjunctival Sutureless Vitrectomy System market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
Major global manufacturers of 25G Transconjunctival Sutureless Vitrectomy System include Alcon, Bausch + Lomb, Dutch Ophthalmic Research Center, NIDEK, Suzhou Synergy Medical Technology, Shanghai Fosun Pharmaceutical Group, Beijing Kangruide Medical Technology, Shanghai New Vision Ophthalmic Equipment, Shenzhen Ophthalmic Equipment, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global 25G Transconjunctival Sutureless Vitrectomy System market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of 25G Transconjunctival Sutureless Vitrectomy System sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of 25G Transconjunctival Sutureless Vitrectomy System manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, 25G Transconjunctival Sutureless Vitrectomy System product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the 25G Transconjunctival Sutureless Vitrectomy System value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 25G Transconjunctival Sutureless Vitrectomy System Product Scope
1.2 25G Transconjunctival Sutureless Vitrectomy System by Type
1.2.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Type (2021, 2025 & 2032)
1.2.2 Standard
1.2.3 Combination
1.3 25G Transconjunctival Sutureless Vitrectomy System by Application
1.3.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Ophthalmology
1.3.3 Other
1.4 Global 25G Transconjunctival Sutureless Vitrectomy System Market Estimates and Forecasts (2021-2032)
1.4.1 Global 25G Transconjunctival Sutureless Vitrectomy System Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global 25G Transconjunctival Sutureless Vitrectomy System Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global 25G Transconjunctival Sutureless Vitrectomy System Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global 25G Transconjunctival Sutureless Vitrectomy System Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global 25G Transconjunctival Sutureless Vitrectomy System Historical Market Scenario by Region (2021-2026)
2.2.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Market Share by Region (2021-2026)
2.2.2 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue Market Share by Region (2021-2026)
2.3 Global 25G Transconjunctival Sutureless Vitrectomy System Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America 25G Transconjunctival Sutureless Vitrectomy System Market Size and Prospects (2021-2032)
2.4.2 Europe 25G Transconjunctival Sutureless Vitrectomy System Market Size and Prospects (2021-2032)
2.4.3 China 25G Transconjunctival Sutureless Vitrectomy System Market Size and Prospects (2021-2032)
2.4.4 Japan 25G Transconjunctival Sutureless Vitrectomy System Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global 25G Transconjunctival Sutureless Vitrectomy System Historical Market Review by Type (2021-2026)
3.1.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Type (2021-2026)
3.1.2 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Type (2021-2026)
3.1.3 Global 25G Transconjunctival Sutureless Vitrectomy System Average Price by Type (2021-2026)
3.2 Global 25G Transconjunctival Sutureless Vitrectomy System Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Forecast by Type (2027-2032)
3.2.2 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue Forecast by Type (2027-2032)
3.2.3 Global 25G Transconjunctival Sutureless Vitrectomy System Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of 25G Transconjunctival Sutureless Vitrectomy System
4 Global Market Size by Application
4.1 Global 25G Transconjunctival Sutureless Vitrectomy System Historical Market Review by Application (2021-2026)
4.1.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Application (2021-2026)
4.1.2 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Application (2021-2026)
4.1.3 Global 25G Transconjunctival Sutureless Vitrectomy System Average Price by Application (2021-2026)
4.2 Global 25G Transconjunctival Sutureless Vitrectomy System Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Forecast by Application (2027-2032)
4.2.2 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue Forecast by Application (2027-2032)
4.2.3 Global 25G Transconjunctival Sutureless Vitrectomy System Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in 25G Transconjunctival Sutureless Vitrectomy System Applications
5 Competition Landscape by Players
5.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales by Player (2021-2026)
5.2 Global Top 25G Transconjunctival Sutureless Vitrectomy System Players by Revenue (2021-2026)
5.3 Global 25G Transconjunctival Sutureless Vitrectomy System Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on 25G Transconjunctival Sutureless Vitrectomy System revenue as of 2025
5.4 Global 25G Transconjunctival Sutureless Vitrectomy System Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of 25G Transconjunctival Sutureless Vitrectomy System, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of 25G Transconjunctival Sutureless Vitrectomy System, Product Type & Application
5.7 Global Key Manufacturers of 25G Transconjunctival Sutureless Vitrectomy System, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America 25G Transconjunctival Sutureless Vitrectomy System Sales by Company
6.1.1.1 North America 25G Transconjunctival Sutureless Vitrectomy System Sales by Company (2021-2026)
6.1.1.2 North America 25G Transconjunctival Sutureless Vitrectomy System Revenue by Company (2021-2026)
6.1.2 North America 25G Transconjunctival Sutureless Vitrectomy System Sales Breakdown by Type (2021-2026)
6.1.3 North America 25G Transconjunctival Sutureless Vitrectomy System Sales Breakdown by Application (2021-2026)
6.1.4 North America 25G Transconjunctival Sutureless Vitrectomy System Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe 25G Transconjunctival Sutureless Vitrectomy System Sales by Company
6.2.1.1 Europe 25G Transconjunctival Sutureless Vitrectomy System Sales by Company (2021-2026)
6.2.1.2 Europe 25G Transconjunctival Sutureless Vitrectomy System Revenue by Company (2021-2026)
6.2.2 Europe 25G Transconjunctival Sutureless Vitrectomy System Sales Breakdown by Type (2021-2026)
6.2.3 Europe 25G Transconjunctival Sutureless Vitrectomy System Sales Breakdown by Application (2021-2026)
6.2.4 Europe 25G Transconjunctival Sutureless Vitrectomy System Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China 25G Transconjunctival Sutureless Vitrectomy System Sales by Company
6.3.1.1 China 25G Transconjunctival Sutureless Vitrectomy System Sales by Company (2021-2026)
6.3.1.2 China 25G Transconjunctival Sutureless Vitrectomy System Revenue by Company (2021-2026)
6.3.2 China 25G Transconjunctival Sutureless Vitrectomy System Sales Breakdown by Type (2021-2026)
6.3.3 China 25G Transconjunctival Sutureless Vitrectomy System Sales Breakdown by Application (2021-2026)
6.3.4 China 25G Transconjunctival Sutureless Vitrectomy System Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan 25G Transconjunctival Sutureless Vitrectomy System Sales by Company
6.4.1.1 Japan 25G Transconjunctival Sutureless Vitrectomy System Sales by Company (2021-2026)
6.4.1.2 Japan 25G Transconjunctival Sutureless Vitrectomy System Revenue by Company (2021-2026)
6.4.2 Japan 25G Transconjunctival Sutureless Vitrectomy System Sales Breakdown by Type (2021-2026)
6.4.3 Japan 25G Transconjunctival Sutureless Vitrectomy System Sales Breakdown by Application (2021-2026)
6.4.4 Japan 25G Transconjunctival Sutureless Vitrectomy System Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Alcon
7.1.1 Alcon Company Information
7.1.2 Alcon Business Overview
7.1.3 Alcon 25G Transconjunctival Sutureless Vitrectomy System Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Alcon 25G Transconjunctival Sutureless Vitrectomy System Products Offered
7.1.5 Alcon Recent Development
7.2 Bausch + Lomb
7.2.1 Bausch + Lomb Company Information
7.2.2 Bausch + Lomb Business Overview
7.2.3 Bausch + Lomb 25G Transconjunctival Sutureless Vitrectomy System Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Bausch + Lomb 25G Transconjunctival Sutureless Vitrectomy System Products Offered
7.2.5 Bausch + Lomb Recent Development
7.3 Dutch Ophthalmic Research Center
7.3.1 Dutch Ophthalmic Research Center Company Information
7.3.2 Dutch Ophthalmic Research Center Business Overview
7.3.3 Dutch Ophthalmic Research Center 25G Transconjunctival Sutureless Vitrectomy System Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Dutch Ophthalmic Research Center 25G Transconjunctival Sutureless Vitrectomy System Products Offered
7.3.5 Dutch Ophthalmic Research Center Recent Development
7.4 NIDEK
7.4.1 NIDEK Company Information
7.4.2 NIDEK Business Overview
7.4.3 NIDEK 25G Transconjunctival Sutureless Vitrectomy System Sales, Revenue and Gross Margin (2021-2026)
7.4.4 NIDEK 25G Transconjunctival Sutureless Vitrectomy System Products Offered
7.4.5 NIDEK Recent Development
7.5 Suzhou Synergy Medical Technology
7.5.1 Suzhou Synergy Medical Technology Company Information
7.5.2 Suzhou Synergy Medical Technology Business Overview
7.5.3 Suzhou Synergy Medical Technology 25G Transconjunctival Sutureless Vitrectomy System Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Suzhou Synergy Medical Technology 25G Transconjunctival Sutureless Vitrectomy System Products Offered
7.5.5 Suzhou Synergy Medical Technology Recent Development
7.6 Shanghai Fosun Pharmaceutical Group
7.6.1 Shanghai Fosun Pharmaceutical Group Company Information
7.6.2 Shanghai Fosun Pharmaceutical Group Business Overview
7.6.3 Shanghai Fosun Pharmaceutical Group 25G Transconjunctival Sutureless Vitrectomy System Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Shanghai Fosun Pharmaceutical Group 25G Transconjunctival Sutureless Vitrectomy System Products Offered
7.6.5 Shanghai Fosun Pharmaceutical Group Recent Development
7.7 Beijing Kangruide Medical Technology
7.7.1 Beijing Kangruide Medical Technology Company Information
7.7.2 Beijing Kangruide Medical Technology Business Overview
7.7.3 Beijing Kangruide Medical Technology 25G Transconjunctival Sutureless Vitrectomy System Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Beijing Kangruide Medical Technology 25G Transconjunctival Sutureless Vitrectomy System Products Offered
7.7.5 Beijing Kangruide Medical Technology Recent Development
7.8 Shanghai New Vision Ophthalmic Equipment
7.8.1 Shanghai New Vision Ophthalmic Equipment Company Information
7.8.2 Shanghai New Vision Ophthalmic Equipment Business Overview
7.8.3 Shanghai New Vision Ophthalmic Equipment 25G Transconjunctival Sutureless Vitrectomy System Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Shanghai New Vision Ophthalmic Equipment 25G Transconjunctival Sutureless Vitrectomy System Products Offered
7.8.5 Shanghai New Vision Ophthalmic Equipment Recent Development
7.9 Shenzhen Ophthalmic Equipment
7.9.1 Shenzhen Ophthalmic Equipment Company Information
7.9.2 Shenzhen Ophthalmic Equipment Business Overview
7.9.3 Shenzhen Ophthalmic Equipment 25G Transconjunctival Sutureless Vitrectomy System Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Shenzhen Ophthalmic Equipment 25G Transconjunctival Sutureless Vitrectomy System Products Offered
7.9.5 Shenzhen Ophthalmic Equipment Recent Development
8 25G Transconjunctival Sutureless Vitrectomy System Manufacturing Cost Analysis
8.1 25G Transconjunctival Sutureless Vitrectomy System Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of 25G Transconjunctival Sutureless Vitrectomy System
8.4 25G Transconjunctival Sutureless Vitrectomy System Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 25G Transconjunctival Sutureless Vitrectomy System Distributors List
9.3 25G Transconjunctival Sutureless Vitrectomy System Customers
10 25G Transconjunctival Sutureless Vitrectomy System Market Dynamics
10.1 25G Transconjunctival Sutureless Vitrectomy System Industry Trends
10.2 25G Transconjunctival Sutureless Vitrectomy System Market Drivers
10.3 25G Transconjunctival Sutureless Vitrectomy System Market Challenges
10.4 25G Transconjunctival Sutureless Vitrectomy System Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global 25G Transconjunctival Sutureless Vitrectomy System market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 132
USD 4900.00
(Single User License)
The global market for 25G Transconjunctival Sutureless Vitrectomy System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-08
Pages: 97
USD 3950.00
(Single User License)
The global 25G Transconjunctival Sutureless Vitrectomy System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-08
Pages: 115
USD 2900.00
(Single User License)
The global 25G Transconjunctival Sutureless Vitrectomy System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 141
USD 4900.00
(Single User License)
The global 25G Transconjunctival Sutureless Vitrectomy System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 77
USD 4250.00
(Single User License)
The global market for 25G Transconjunctival Sutureless Vitrectomy System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 98
USD 3950.00
(Single User License)
The global market for 25G Transconjunctival Sutureless Vitrectomy System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 87
USD 2900.00
(Single User License)
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
Published Date: 2024-10-31
Pages: 134
USD 4900.00
(Single User License)
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
Published Date: 2024-10-31
Pages: 100
USD 3950.00
(Single User License)
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
Published Date: 2024-10-31
Pages: 80
USD 2900.00
(Single User License)
The global 25G Transconjunctival Sutureless Vitrectomy System market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 132
The global market for 25G Transconjunctival Sutureless Vitrectomy System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-08
Pages: 97
The global 25G Transconjunctival Sutureless Vitrectomy System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-08
Pages: 115
The global 25G Transconjunctival Sutureless Vitrectomy System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 141
The global 25G Transconjunctival Sutureless Vitrectomy System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 77
The global market for 25G Transconjunctival Sutureless Vitrectomy System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 98
The global market for 25G Transconjunctival Sutureless Vitrectomy System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 87
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
Published: 2024-10-31
Pages: 134
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
Published: 2024-10-31
Pages: 100
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
Published: 2024-10-31
Pages: 80
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now